The challenges and achievements involved in implementing Quality of Life research in cancer clinical trials

European Journal of Cancer

Volumn 39, Issue 3, 2003, Pages 275-285

  Bottomley, A ^a   Vanvoorden, V ^a   Flechtner, H ^b   Therasse, P ^a  

^a EORTC DATA CENTER   (Belgium)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Cancer; Clinical trials; EORTC; Methodology; QOL

Indexed keywords

ARTICLE; CANCER RESEARCH; CLINICAL TRIAL; CULTURAL ANTHROPOLOGY; EDUCATION; HUMAN; MEDICAL RESEARCH; PRIORITY JOURNAL; QUALITY OF LIFE; TREATMENT OUTCOME;

CLINICAL TRIALS; CROSS-CULTURAL COMPARISON; DATA COLLECTION; HUMANS; NEOPLASMS; PATIENT COMPLIANCE; PRACTICE GUIDELINES; QUALITY OF LIFE; RESEARCH;

EID: 0037304940     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(02)00729-3     Document Type: Article

References (31)

1. Fallowfield L. Compliance issues in quality of life assessment. experiences of two Cancer Research Campaign sponsored groups Statist. Med. 17:1998;541-546.
2. Bernhard J., Cella D.F., Coates A.S.et al. Missing quality of life data in cancer clinical trials. serious problems and challenges Statist. Med. 17:1998;517-532.
3. Osoba D. Lessons learned from measuring health-related quality of life in oncology. J. Clin. Oncol. 12:1994;608-616.
4. Velikova G., Stark D., Selby P. Quality of Life instruments in oncology. Eur. J. Cancer. 35:1999;1571-1580.
5. Aaronson N.K., Ahmedzai S., Bergman B.et al. The European Organization for Research and Treatment of Cancer QLQ-C30. a quality-of-life instrument for use in international clinical trials in oncology J. Natl. Cancer Inst. 85:1993;365-376.
6. Gotay C.C., Wilson M. Use of quality-of-life outcome assessments in current cancer clinical trials. Eval. Health Prof. 21:1998;157-178.
7. Fayers P., Bottomley A. Quality of Life research within the EORTC - the EORTC QLQ-C30, on behalf of the EORTC Quality of Life Group. Eur. J. Cancer. 38:2002;S125-S133.
8. Blazeby J, Sprangers M, Cull A, Groenvold M, Bottomley A, on behalf of the EORTC Quality of Life Group. EORTC Quality of Life Group Guidelines for Developing Questionnaire Modules, 3rd edn. Brussels, EORTC, 2002.
9. Bottomley A., Vachalec S., Bjordal K., Blazeby J., Flechtner H., Ruyskart P. The development and utilisation of the European Organization for Research and Treatment of Cancer Quality of Life Group Item Bank. Eur. J. Cancer. 38:2002;1611-1614.
10. Cull A, Sprangers M, Bjordal K, Aaronson N, West K, Bottomley A, on behalf of the EORTC Quality of Life Group. EORTC Quality of Life Group Translation Procedure, 2nd edn. Brussels, EORTC, 2002.
11. Browman G.P. Science, language, intuition and the many meanings of quality of life. J. Clin. Oncol. 17:1999;1651-1653.
12. Fossa S.D., Aaronson N.K., Newling D.et al. Quality of life and treatment of hormone and resistant metastatic prostatic cancer. Eur. J. Cancer. 26:1990;1133-1136.
13. Curran D., van Dongen J.P., Aaronson N.K.et al. Quality of life of early-stage breast cancer patients treated with radical mastectomy or breast-conserving procedures. results of EORTC trial 10801 Eur. J. Cancer. 34:1998;307-315.
14. de Haes J., Curran D., Young T. Quality of life evaluation in oncological clinical trials - the EORTC model. Eur. J. Cancer. 37:2000;821-825.
15. Young T, de Haes H, Curran D, on behalf of the EORTC Quality of Life Study Group. EORTC Guidelines for Assessing Quality of Life in EORTC Clinical Trials, 2nd edn. Brussels, EORTC, 2002.
16. Bottomley A. Quality of life in cancer clinical trials - an overview of approaches within the EORTC. In International Society for Pharmaeconomics and Outcomes Research, 4th Annual European Congress, Cannes, France, November 2001 [published in Value in Health, 4, 438].
17. Kiebert G.M., Curran D., Aaronson N.K. Quality of life as an endpoint in EORTC clinical trials. Statist. Med. 17:1998;561-569.
18. Osoba D., Dancey J., Zee B., Myles J., Pater J. Health-related quality of life studies of the National Cancer Institute of Canada Clinical Trials Group. Monogr. Natl. Cancer Inst. 20:1996;107-111.
19. Lee C.W., Chi K.N. The standard of reporting of health-related quality of life in clinical cancer trials. J. Clin. Epidemiol. 53:2000;451-458.
20. Sanders C., Egger M., Donovan J., Tallon D., Frankel S. Reporting on quality of life in randomised controlled trials. bibliographic study Br. Med. J. 317:1998;1191-1194.
21. Young T., Maher J. Collecting quality of life data in EORTC clinical trials - what happens in practice? Psycho-Oncology. 8:1999;260-263.
22. Fayers P.M., Machin D. Quality of Life - Assessment, Analysis and Interpretation. 2000;John Wiley & Sons, Chichester.
23. Hahn E.A., Webster K.A., Cella D., Fairclough D.L. Missing data in quality of life research in Eastern Cooperative Oncology Group (ECOG) clinical trial. problems and solutions Statist. Med. 17:1998;547-559.
24. Curran D., Molenberghs G., Fayers P., Machin D. Aspects of incomplete quality of life data in randomized trials: ii: missing forms. Statist. Med. 17:1998;697-709.
25. Fairclough D.L., Peterson H.F., Chang V. Why are missing quality of life data a problem in clinical trials of cancer therapy? Statist. Med. 17:1998;667-677.
26. Moinpour C.M. Do quality of life assessments make a difference in the evaluation of cancer treatments? Control Clin. Trials. 18:1997;311-317.
27. Therasse P, Bottomley A. The clinical impact of HRQOL studies from RCTs in advanced breast cancer patients undergoing systemic therapy. In Proceedings of the 2002 Annual International Society for Quality Of Life Research, Orlando. Quality of Life Research (ISOQOL), 2002.
28. Osoba D., Zee B. Completion rates in health-related quality-of-life assessment. approach of the National Cancer Institute of Canada Clinical Trials Group Statist. Med. 17:1998;603-612.
29. Babbie E. The Practice of Social Research. 6th edn. 1992;Wadsworth, Belmont, CA.
30. Fairclough D.L. Design and Analysis of Quality of Life Studies in Clinical Trials. Interdisciplinary Statistics. 2002;Chapman and Hall, CRC, London.
31. Bottomley A., Efficace F., Fayers P. Standards are needed for quality of life in clinical trials. Br. Med. J. 324:2002;1156.